Renal arterial reactivity to potassium, noradrenaline, and neuropeptide Y and association with urinary albumin excretion in the diabetic rat

Journal of Diabetes and its Complications

Volumn 11, Issue 5, 1997, Pages 279-286

  Torffvit, Ole ^a   Adamsson, Marie ^a   Edvinsson, Lars ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; GLUCOSE; INSULIN; NEUROPEPTIDE Y; NORADRENALIN; POTASSIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; KIDNEY BLOOD FLOW; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL ARTERY; STREPTOZOCIN DIABETES; URINARY EXCRETION;

ALBUMINURIA; ANIMALS; ARTERIES; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; KIDNEY; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NEUROPEPTIDE Y; NOREPINEPHRINE; POTASSIUM; RATS; RATS, WISTAR; RENAL ARTERY;

EID: 0030823933     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(96)00041-4     Document Type: Article

References (46)

1. Harris RD, Steffes MW, Bilous RW, Sutherland DER, Mauer SM: Global glomerular sclerosis and glomerular arteriolar hyalinosis in insulin dependent diabetes. Kidney Int 40:107-114, 1991
2. Platt JF, Rubin JM, Ellis JH: Diabetic nephropathy: Evaluation with renal duplex doppler US. Radiology 190:343-346, 1994.
3. Christensen T, Neubauer B: Increased arterial wall stiffness and thickness in medium-sized arteries in patients with insulin-dependent diabetes mellitus. Acta Radiol 29:299-302, 1988.
4. Airaksinen KEJ, Salmela PI, Linnaluoto MK, Ikäheimo MJ, Ahola K, Ryhänen LJ: Diminished arterial elasticity in diabetes: Association with fluorescent advanced glycosylation end products in collagen. Cardiovasc Res 27:942-945, 1993.
5. Arendshorst WJ, Navar LG: Renal circulation and glomerular hemodynamics, in Schrier RW, Gottschalk CW (eds), Diseases of the Kidney, 5th ed, vol I. London, Little, Brown and Company, 1993, pp. 65-117.
6. Heller J: Effect of vasoactive mediators on renal haemodynamics. Nephrol Dial Transplant 2:197-204, 1987.
7. Uddman R, Ekblad E, Edvinsson L, Håkanson R, Sundler F: Neuropeptide Y-like immunoreactivity in perivascular nerve fibres of the guinea-pig. Regul Pept 10:243-257, 1985.
8. Andersson D, Brunkwall J, Bergqvist D, Edvinsson L: Diminished contractile responses to neuropeptide Y of arteries from diabetic rabbits. J Auton Nerv Syst 37:215-222, 1992.
9. Weidman P, Beretta-Picoli C, Keusch G, Glück Z, Mujagic M, Grimm M, Meier A, Ziegler WH: Sodium-volume factor, cardiovascular reactivity and hypotensive mechanism of diuretic therapy in mild hypertension associated with diabetes mellitus. Am J Med 67:779-784, 1979.
10. Christlieb AR, Janka H-U, Kraus B, Gleason RE, Icasas-Cabral EA, Aiello LM, Cabral BV, Solano A: Vascular reactivity to angiotensin II and to norepinephrine in diabetic subjects. Diabetes 25:268-274, 1976.
11. Ramanadham S, Lyness WH, Tenner TE: Alterations in aortic and tail artery reactivity to agonists after streptozotocin treatment. Can J Physiol Pharmacol 62:418-423, 1984.
12. Owen MP, Carrier GO: Calcium dependence of norepinephrine-induced vascular contraction in experimental diabetes. J Pharmacol Exp Ther 212:253-258, 1980.
13. Özcelikay AT, Pekiner C, Ari N, Öztürk Y, Özüari A, Altan VM: The effect of vanadyl treatment on vascular responsiveness of streptozotocin-diabetic rats. Diabetologia 37:572-578, 1994.
14. Sjögren A, Edvinsson L: Vasomotor changes in isolated coronary arteries from diabetic rats. Acta Physiol Scand 134:429-436, 1988.
15. Head RJ, Hempstead J, Berkowitz BA: Catecholamines in the vasculature of the rat and rabbit: Dopamine, norepinephrine, epinephrine. Blood Vessels 19:135-147, 1982.
16. Zhang B-L, Sassard J: Eicosanoid-dependence of responses of pre-but not postglomerular vessels to noradrenaline in rat isolated kidneys. Br J Pharmacol 110:235-238, 1993.
17. Bhardwaj R, Moore PK: Increased vasodilator response to acetylcholine of renal blood vessels from diabetic rats. J Pharm Pharmacol 40:739-742, 1988.
18. Torffvit O, Wieslander J: A simplified enzyme-linked immunosorbent assay for urinary albumin. Scand J Clin Lab Invest 46:545-548, 1986.
19. Högestätt ED, Andersson K-E, Edvinsson L: Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels. Acta Physiol Scand 117:49-61, 1983.
20. Tønder KJH, Aukland K: Interlobular arterial pressure in the rat kidney. Renal Physiol Basel 2:214-221, 1979/80.
21. Reinilä A: Long-term effects of untreated diabetes on the arterial wall in rat. An ultrastructural study. Diabetologia 20:205-212, 1981.
22. Menè P, Pugliese G, Pricci F, Mario UD, Cinotti GA, Pugliese F: High glucose inhibits cytosolic calcium signaling in cultured rat mesangial cells. Kidney Int 43:585-591, 1993.
23. Tammesild PJ, Hodgson WC, King RG: Increased sensitivity to endothelin-1 in isolated krebs'-perfused kidneys of streptozotocin-diabetic rats. Clin Exp Pharmacol Physiol 19:261-265, 1992.
24. Scarborough NL, Carrier GO: Nifedipine and alpha adrenoceptors in rat aorta: II. Role of extracellular calcium in enhanced alpha-2 adrenoceptor mediated contraction in diabetes. J Pharmacol Exp Ther 231:603-609, 1984.
25. MacLeod KM, McNeill JH: The influence of chronic experimental diabetes on contractile responses of rat isolated blood vessels. Can J Physiol Pharmacol 63:52-57, 1985.
26. MacLeod KM: The effect of insulin treatments on changes in vascular reactivity in chronic, experimental diabetes. Diabetes 34:1160-1167, 1985.
27. Turlapaty PDMV, Lum G, Altura BM: Vascular responsiveness and serum biochemical parameters in alloxan diabetes mellitus. Am J Physiol 239:E412-E421, 1980.
28. Head RJ, Longhurst PA, Panek RL, Stitzel RE: A contrasting effect of the diabetic state upon the contractile responses of aortic preparations from the rat and rabbit. Br J Pharmacol 91:275-286, 1987.
29. Pfaffman MA, Ball CR, Darby A, Hilman R: Insulin reversal of diabetes-induced inhibition of vascular contractility in the rat. Am J Physiol 242:H490-H495, 1982.
30. Murray P, Pitt B, Webb RC: Ramipril prevents hypersensitivity to phenylephrine in aorta from streptozotocin-induced diabetic rats. Diabetologia 37:664-670, 1994.
31. Abebe W, Harris KH, MacLeod KM: Enhanced contractile responses of arteries from diabetic rats to α1-adreno-receptor stimulation in the absence and presence of extracellular calcium. J Cardiovasc Pharmacol 16:239-248, 1990.
32. Kamata K, Miyata N, Kasuya Y: Mechanisms of increased responses of the aorta to α-adrenoceptor agonists in streptozotocin-induced diabetic rats. J Pharmacobio-dyn 11:707-713, 1988.
33. Abebe W, MacLeod KM: Enhanced arterial contractility to noradrenaline in diabetic rats is associated with increased phosphoinositide metabolism. Can J Physiol Pharmacol 69:355-361, 1991.
34. Rinaldi GJ, Cingolani HE: Effect of diabetes on fast response to norepinephrine in rat aorta. Diabetes 41:30-34, 1992.
35. Sullivan S, Sparks HV: Diminished contractile response of aortas from diabetic rabbits. Am J Physiol 236:H301-H306, 1979.
36. Morff RJ: Microvascular reactivity to norepinephrine at different arteriolar levels and durations of streptozotocin-induced diabetes. Diabetes 39:354-360, 1990.
37. Burnstock G: Overview: Purinergic mechanisms. Ann NY Acad Sci 603:1-17, 1990.
38. Ahlborg G, Weitzberg E, Lundberg JM: Splanchnic and renal vasoconstriction during neuropeptide Y infusion in healthy humans. Clin Physiol 12:145-153, 1992.
39. Allen JM, Raine AEG, Ledingham JGG, Bloom SR: Neuropeptide Y: A novel renal peptide with vasoconstrictor and natriuretic activity. Clin Sci 68:373-377, 1985.
40. Hackenthal E, Aktories K, Jakobs KH, Lang RE: Neuropeptide Y inhibits renin release by a pertussis toxin-sensitive mechanism. Am J Physiol 252:F543-F550, 1987.
41. Edvinsson L, Emson P, McCulloch J, Tatemoto K, Uddman R: Neuropeptide Y: Immunocytochemical localization to and effect upon feline pial arteries and veins in vitro and in situ. Acta Physiol Scand 122:155-163, 1984.
42. Wahlestedt C, Edvinsson L, Ekblad E, Håkansson R: Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: Mode of action. J Pharmacol Exp Ther 234:735-741, 1985.
43. Edvinsson L, Håkansson R, Steen S, Sundler F, Uddman R, Wahlestedt C: Innervation of human omental arteries and veins and vasomotor responses to noradrenaline, neuropeptide Y, substance P and vasoactive intestinal peptide. Regul Pept 12:67-79, 1985.
44. Jansen I, Uddman R, Hocherman M, Ekman R, Jensen K, Olesen J, Stiernholm P, Edvinsson L: Localization and effects of neuropeptide Y, vasoactive intestinal polypeptide, substance P, and calcitonin gene-related peptide in human temporal arteries. Ann Neurol 20:496-501, 1986.
45. Fallgren B, Arlock P, Edvinsson L: Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction by an intracellular calcium-dependent mechanism. J Auton Nerv Sys 44:151-159, 1993.
46. Mauer SM, Azar S, Steffes MW, Brown DM: The effects of normalization of dietary protein intake and carotid artery ligation on the renal autoregulatory abnormalities of streptozotocin diabetic rats. J Diabet Complications 8:89-96, 1994.